Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1438 of 6351
-
New hope for kidney disease patients: finerenone trial aims to reduce protein leakage
Disease control By invitation onlyStudy to demonstrate efficacy of finerenone when compared to placebo in reducing albuminuria in participants with chronic kidney disease (CKD) not using renin-angiotensin-system (RAS) inhibitors.
Phase 3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can lung imaging guide ventilator settings to save lives in ARDS?
Disease control Recruiting nowAcute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of …
Sponsor: Southeast University, China • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to outsmart resistant prostate cancer
Disease control Recruiting nowTITLE: Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9bMS in Patients with Prostate Cancer (PHAROS) STUDY DESCRIPTION: Prostate cancer (PC) patients receive androgen deprivation therapy (ADT), but recalcitrant disease recurs typic…
Phase 1 • Sponsor: TechnoGenesys, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
AI eye on your gut: could Computer-Aided colonoscopy cut cancer risk?
Prevention Recruiting nowThe occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves…
Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Can a dead bug stop chemo side effects? new trial aims to find out.
Prevention Recruiting nowThe incidence of chemotherapy-induced diarrhea (CID) is closely related to the types of anticancer drugs. Combination chemotherapy regimens such as fluorouracil derivatives and irinotecan, as well as tyrosine kinase inhibitors like neratinib, are associated with a high severity a…
Sponsor: Shenzhen Hospital of Southern Medical University • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
New hope for rare thymic cancer: targeted drug trial launches
Disease control Recruiting nowThe goal of this clinical trial is to learn if drug Sac-TMT works to treat Thymic Carcinoma. It will also learn about the safety of Sac-TMT. The main questions it aims to answer are: * How effective is drug Sac-TMT in treating Thymic Carcinoma? * What adverse events (AEs) do par…
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a week of ketamine pills speed up depression relief?
Symptom relief Ongoing* The goal of this clinical trial is to explore if the treatment with ketamine tablets in addition to standard antidepressant therapy can reduce depressive symptoms in adults with Major Depressive Disorder. The main question it aims to answer is: Does adjunctive ketamine therapy …
Phase 2 • Sponsor: Daniel Lindqvist • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can Pre-Surgery hormone therapy help lobular breast cancer patients?
Disease control Recruiting nowThe purpose of this study is to look at how effective neoadjuvant (before surgery) endocrine therapy (NET) is in participants with invasive lobular carcinoma (ILC) who have breast-conserving surgery (BCS). The main purpose of the study is to see if NET reduces the chance of havin…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Electric pulses zap lung tumors before surgery in new trial
Disease control Recruiting nowA prospective, single-arm, non-randomized, single-center, open-label, treat and resect study following patients through surgical resection. The study is designed to evaluate the safety and feasibility of the Aliya EX System for the ablation of pulmonary lesions using pulsed elect…
Sponsor: Galvanize Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Robots take on tricuspid valve repair in tiny early trial
Disease control Recruiting nowValvular heart disease (VHD), caused by abnormalities in heart valves, can lead to severe complications such as heart failure and death, with approximately 220 million affected patients worldwide. The prevalence of VHD continues to grow alongside the aging global population. Tran…
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Mapping the Real-World treatment landscape for IgA nephropathy
Knowledge-focused CompletedThe aim of this study was to characterize real-world treatment patterns, including therapy sequences, escalation, and duration, and treatment outcomes in IgA nephropathy (IgAN) patients in the United States (US). The study used data which has detailed information on renal biopsy …
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
AI tool aims to revolutionize lung cancer screening
Diagnosis Recruiting nowThis research study aims to investigate methods for enhancing lung cancer screening. The study will investigate whether an artificial intelligence (AI) tool, known as Sybil, can aid in predicting the risk of lung cancer. The investigators will also examine whether expanding the s…
Sponsor: University of Illinois at Chicago • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Could a pill and light combo beat vitiligo?
Disease control Recruiting nowVitiligo affects approximately 1 to 2% of the global population and significantly impacts people's quality of life. areas of high stress. Ritlecitinib, an orally administered inhibitor of JAK3 (Janus kinase)/ TEC (tyrosine kinase expressed in hepatocellular carcinoma) has shown e…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug itepekimab tested for Long-Term safety in nasal polyp patients
Disease control OngoingThis is a double-blind, parallel-group, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments. The primary purpose of this study is to evaluate safety …
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Ear stimulation device offers new hope for Parkinson's tremors
Symptom relief Recruiting nowThis is a prospective, multicenter, randomized, two-period study designed to evaluate the safety and effectiveness of the EarStim System for intermittent relief of motor symptoms in patients with Parkinson's disease experiencing wearing-off phenomena. Adult patients with moderate…
Sponsor: Stoparkinson Healthcare Systems LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New biologic combo aims to spare bladders in cancer fight
Disease control Not yet recruitingThe goal of clinical trial is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With on-Muscle-Invasive Bladder Cancer. The main questions it aims to answer are: 1. Determine the recommend Phase II dose of SPGL008 Alone or in Co…
Phase 1/2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New coiling technique aims to stop Re-Bleeding in severe brain aneurysms
Disease control Recruiting nowThe DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
Sponsor: University of Louisville • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo aims to fight Hard-to-Treat vulvar cancer
Disease control Recruiting nowMITO VULVA-1 is a prospective, single arm, multi-cohorts, phase II trial that aims to assess the activity and the safety of Lenvatinib plus Pembrolizumab in patients with vulvar cancer. 80 patients will be overall enrolled in the study.Three cohorts are planned
Phase 2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Ancient herbs meet AI: could a TCM formula slow kidney failure in diabetes?
Disease control Not yet recruitingWith the help of the 'Traditional Chinese Medicine Specialty Alliance Platform-Multicenter RCT Clinical Research Database,' this platform can be used to conduct scientific research on various aspects of DKD, such as disease prediction, treatment effectiveness evaluation, and recu…
Sponsor: Jiazhen Yin • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Vitamin c boost: could high doses help fight bone marrow cancer?
Disease control Recruiting nowThis is an open-label, phase II clinical trial with safety run-in evaluating the safety, tolerability, and efficacy of IV HDA in combination with azacitidine for participants with MDS.
Phase 2 • Sponsor: Prajwal Dhakal • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC